Agarwal Arjun (CIK 2033974) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Sell ORKA (888 shares), Sell ORKA (699 shares), Buy ORKA (2,000 shares), Buy ORKA (5,833 shares), Sell ORKA (4,190 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 888 | $71,049 |
| 2026-06-22 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 699 | $57,419 |
| 2026-05-18 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Buy | 2,000 | $25,000 |
| 2026-05-18 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Buy | 5,833 | $200,597 |
| 2026-05-18 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 4,190 | $244,465 |
| 2026-05-18 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 4,600 | $272,260 |
| 2026-05-18 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 800 | $48,269 |
| 2026-05-18 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 700 | $42,812 |
| 2026-03-17 | Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sell | 395 | $16,313 |
| 2026-01-23 | Oruka Therapeutics, Inc. (ORKA) | SVP, Finance | Buy | 17,500 | $0 |
Source: SEC Form 4 filings · as of 2026-06-22